Table 1.
Characteristic | n (%) |
---|---|
Age, y Mean 60, range 15–85 | |
≤60 | 41 (41) |
>60 | 59 (59) |
Sex | |
Female | 35 (35) |
Male | 65 (65) |
Karnofsky Performance Score (n = 98) | |
<80 | 37 (38) |
≥80 | 61 (62) |
Histology | |
Primary GBM | 95 (95) |
Secondary GBM | 3 (3) |
Giant cell GBM | 1 (1) |
Gliosarcoma | 1 (1) |
Therapeutic intervention | |
Surgery | 25 (25) |
Surgery/radiotherapy | 4 (4) |
Surgery/radiotherapy/chemotherapy | 71 (71) |
MGMT promoter methylation status (n = 99) | |
Methylated | 67 (68) |
Unmethylated | 32 (32) |
IDH1 | |
Mutation | 6 (6) |
No mutation | 94 (94) |